Ovarian Cancer: Related News

On Our Blog

Pictured: Tari King
Study Suggests Double Mastectomy Often Done Unnecessarily

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

May 22, 2014
Pictured: Kenneth Offit
Twenty Years after BRCA Discovery, Progress in Prevention and Early Detection

Memorial Sloan Kettering Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancers.

May 5, 2014
Pictured: Douglas Levine
Aggressive Ovarian Cancer May Be Caused by a Single Gene Mutation

Researchers have identified a genetic mutation that appears to cause a rare but very aggressive type of ovarian cancer in young women.

April 1, 2014
Pictured: Kenneth Offit, Alexandra Heerdt, Emily Glogowski & Max Gomez
Genetic Counseling, Testing, and Treatment for People with BRCA Gene Mutations

Cancer genetics experts say the discovery of the BRCA gene mutations has transformed the way doctors prevent and treat hereditary cancers. Read the post and watch the video.

March 26, 2014
Pictured: Cancer cell lines
Do Cancer Cell Lines Really Resemble Tumors? Now Researchers Can Tell

A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.

August 26, 2013
Strategies for Women to Cope with Sexual and Vaginal Health Concerns Related to Cancer

Therapies are often available for women dealing with sexual and vaginal health concerns related to cancer and its treatment.

June 14, 2013
Charles Sawyers, Kenneth Offit, and Larry Norton
Three Memorial-Sloan Kettering Researchers Receive Special Awards by the American Society of Clinical Oncology

Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers.

May 22, 2013
Pictured: Yukio Sonoda
Meet Gynecologic Cancer Surgeon Yukio Sonoda

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan Kettering have the benefit of an entire team of physicians having input into their care.

March 27, 2013
Pictured: Dennis Chi & Richard Barakat
Women with Ovarian Cancer Benefit from Treatment at High-Volume Centers

Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.

March 12, 2013
Pictured: Dennis Chi
Meet Gynecologic Cancer Surgeon Dennis Chi

Dr. Chi, Deputy Chief of the Gynecology Service, talks about the way Memorial Sloan Kettering’s research and state-of-the-art care help women with ovarian, cervical, and uterine cancers.

February 13, 2013
Pictured: Richard Barakat
Meet Gynecologic Surgeon Richard Barakat

Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.

December 28, 2012
Pictured: Carol Brown
Meet Gynecologic Cancer Surgeon Carol Brown

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

November 28, 2012
Pictured: Nadeem Abu-Rustum
Meet Gynecologic Surgeon Nadeem Abu-Rustum

Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.

October 22, 2012
Pictured: Richard Barakat
Gynecologic Surgeon Richard Barakat to Be Appointed President of Two Leading Medical Societies

Dr. Barakat will serve as president of two prestigious societies for gynecologic cancer, allowing him to influence how women with these cancers are cared for both in the United States and around the world.

October 1, 2012
Pictured: Jane McGrath
Jane’s Story about Ovarian Cancer

When 45-year-old Jane learned she had a tumor in her ovary, she came to Memorial Sloan Kettering for surgery and chemotherapy.

August 7, 2012
Pictured: Memorial Sloan Kettering logo
Memorial Sloan Kettering Made Major Contributions to Cancer Advances in 2011

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.

February 6, 2012
Pictured: Paul Sabbatini
Oncologist Paul Sabbatini Talks About New Strategies to Treat Ovarian Cancer

Medical oncologist Paul Sabbatini, a specialist in treating gynecologic cancers, leads a clinical research program seeking to improve treatments for ovarian cancer by harnessing the power of the immune system.

October 31, 2011
Pictured: Douglas Levine
Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.

October 11, 2011
Pictured: Jedd Wolchok & Paul Chapman
Memorial Sloan Kettering Physician-Scientists Present Significant Clinical Cancer Research Advances at ASCO Annual Meeting

In an extraordinary demonstration of excellence, five Memorial Sloan Kettering physician-scientists were selected to participate in the press program at the 2011 American Society of Clinical Oncology annual meeting, held June 3-7 in Chicago.

July 1, 2011

Related Media Coverage

Drug Used to Treat Kidney Cancer May Hold Off Relapses of Ovarian Cancer

Gynecologic Medical Oncology Service Chief Carol Aghajanian commented on a study that found that a drug used to treat kidney cancer may delay relapses in women with ovarian cancer.

June 2, 2013
First Comprehensive Analysis Of Gene Mutations In Ovarian Cancer Brings Patients One Step Closer To Personalized Medicine

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.

June 29, 2011
Carol Aghajanian
New Drug Combination Slows Tumor Growth For Recurrent Ovarian Cancer

Bevacizumab (Avastin®) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer, according to a new study. Results from the phase III “OCEANS” trial were presented today by the lead author, Carol Aghajanian, MD, of Memorial Sloan Kettering Cancer Center, at the 2011 annual meeting of the American Society of Clinical Oncology.

June 4, 2011